Ento Proteins Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.38 M
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 Cr
- Revenue Growth %
- Profit Growth -57135.04%
- Ebitda -36081.32%
- Net Worth -9233.52%
- Total Assets 13942.69%
About Ento Proteins
Ento Proteins Private Limited (EPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 March 2021 (Three years and ten months 22 days old ). Its registered office is in Dakshina Kannada, Karnataka, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.38 M.
The company currently has active open charges totaling ₹3.50 Cr.
Kalandan Haris, Kalandan Arif, and Kalandan Althaf serve as directors at the Company.
Company Details
- Location
Dakshina Kannada, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U15209KA2021PTC145044
- Company No.
145044
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2021
- Date of AGM
09 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Ento Proteins?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalandan Haris  | Director | 08-Mar-2021 | Current |
| Kalandan Arif | Director | 08-Mar-2021 | Current |
| Kalandan Althaf | Director | 08-Mar-2021 | Current |
Financial Performance of Ento Proteins.
Ento Proteins Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 57135.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 9233.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ento Proteins?
In 2022, Ento Proteins had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mukka Proteins LimitedKalandan Haris, Kalandan Arif and 1 more are mutual person
Haris Marine Products Private LimitedKalandan Haris, Kalandan Arif and 1 more are mutual person
Shipwaves Online LimitedKalandan Haris and Kalandan Althaf are mutual person
Bearys Associates LlpKalandan Haris is a mutual person
- Ocean Proteins Private Limited
Kalandan Haris, Kalandan Arif and 1 more are mutual person
- Atlantic Marine Products Private Limited
Kalandan Haris and Kalandan Arif are mutual person
Charges (Loans)
₹35.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 2023 | Hdfc Bank Limited | ₹3.50 Cr | Open |
How Many Employees Work at Ento Proteins?
Ento Proteins has a workforce of 4 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ento Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ento Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.